PATENT CLAIM ANALYSIS

Application Number: 15779227
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["435", "440000"]

Abstract:
A DNA methylation editing kit comprises: (1) a fusion protein of inactivated CRISPR-associated endonuclease Cas9 (dCas9) having no nuclease activity and a tag peptide array in which plural tag peptides are linked by linkers, or an RNA or DNA coding therefor; (2) a fusion protein(s) of a tag peptide-binding portion and a methylase or demethylase, or an RNA(s) or DNA(s) coding therefor; and (3) a guide RNA(s) (gRNA(s)) comprising a sequence complementary to a DNA sequence within 1 kb of a desired site of methylation or demethylation, or a DNA(s) expressing the gRNA(s).

Claim (Index 18):
The DNA methylation editing method according to  claim 17 , wherein the fusion proteins of the (1) and/or (2) further comprise a selection marker.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 93.0
- Lexical Diversity: 2.07937
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15127087', '15889368', '15329925', '14775930', '14775869']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6399589406333652
- 35 USC 102 Novelty (BERT): 0.5098622231885487
- Combined Prediction Score: 0.6269492688888836
- Mean Citation Score: 302.420786
- Max Citation Score: 317.0796
- Similarity Product: 269.9219638865948

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test